mofezolac has been researched along with Arthritis, Rheumatoid in 1 studies
mofezolac: Cyclooxygenase 1 inhibitor; structure in first source; RN from Toxlit
Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Onodera, M | 1 |
| Horiuchi, Y | 1 |
| Nakahama, K | 1 |
| Muneta, T | 1 |
| Mano, Y | 1 |
| Morita, I | 1 |
1 other study available for mofezolac and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Induction of cyclooxygenase-1 in cultured synovial cells isolated from rheumatoid arthritis patients.
Topics: Arthritis, Rheumatoid; Blotting, Western; Cells, Cultured; Culture Media, Conditioned; Cyclooxygenas | 2004 |